Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
Fujifilm Diosynth CEO marks 2025 as era of expansion execution
By late summer, Fujifilm Diosynth's CEO expects “basically half” of the company’s $8 billion in manufacturing investments to be “in operation."
Fraiser Kansteiner
Jan 24, 2025 12:12pm
CDMO Joinn wraps up purchase of Lonza biologics plant in China
Jan 23, 2025 9:45am
Sales up 23% for Korean CDMO powerhouse Samsung Biologics
Jan 22, 2025 11:41am
Kindeva unit snares $129M to supply US with nerve agent antidote
Jan 22, 2025 9:18am
Sanofi hit with warning letter at Massachusetts ingredient plant
Jan 21, 2025 12:26pm
Atara hit with cell therapy clinical hold after FDA inspection
Jan 21, 2025 9:59am
